30670592

Summary
Title
Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2.
Authors
  • van den Bijgaart RJE
  • Kroesen M
  • Wassink M
  • Brok IC
  • Kers-Rebel ED
  • Boon L
  • Heise T
  • van Scherpenzeel M
  • Lefeber DJ
  • Boltje TJ
  • den Brok MH
  • Hoogerbrugge PM
  • Büll C
  • Adema GJ
Source
J Biol Chem
Publication Date
2019 Mar 22
PubMed ID
30670592

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024